
Hubei Biocause Soars 22% to Day High of CNY 15.74 Amid Strong Performance
2025-10-23 17:52:13Hubei Biocause Heilen Pharmaceutical Co., Ltd. has seen notable stock activity, rising significantly today and over the past week. Despite a strong one-year performance, the company faces challenges, including a low Return on Capital Employed and declining net sales, alongside six consecutive quarters of negative results.
Read MoreNo announcement available
Corporate Actions
No corporate action available






